VTRS - Otsuka's PTSD therapy draws efficacy concerns at FDA ahead of AdCom meeting
2025-07-16 14:25:11 ET
More on Otsuka Holdings, H. Lundbeck A/S
- Lundbeck Delivering On The Financials, But Needs Some Positive Clinical Drivers
- Vera plunges as Otsuka outperforms with IgA nephropathy therapy
- Seeking Alpha’s Quant Rating on Otsuka Holdings
- Historical earnings data for Otsuka Holdings
- Dividend scorecard for Otsuka Holdings